Precision For Medicine

Precision for Medicine is a global leader in advancing technical operations and providing manufacturing solutions for the pharmaceutical and life sciences industries. They offer a comprehensive suite of services from ideation through commercialization, including preclinical development, early and late phase development, IVD & CDx solutions, biospecimen services, manufacturing, and data intelligence. Their focus is on helping clients bring innovative therapies to patients faster and more efficiently.

With over 3,200 team members and over 40 offices in North America, Europe, and Asia-Pacific, Precision for Medicine boasts a proven track record of success. They have fulfilled over 100 technical operations partnerships with a variety of clients including pharma, biotech, vaccines, cell and gene, mRNA, radioligand, academia, hospitals, financial institutions, CMO and CDMOs, med device, non-profits, and government agencies. Precision for Medicine is part of Precision Medicine Group and is dedicated to improving the lives of patients around the world.

Precision For Medicine is a global leader in precision medicine, focused on supporting and advancing life-changing therapies for patients in need. Their mission is to transform the drug development process by bringing together laboratory expertise, clinical trial excellence, manufacturing experience, and data intelligence. They are dedicated to accelerating research, development, and manufacturing while reducing costs and increasing the probability of approval for innovative treatments, ultimately empowering access for patients.

Precision for Medicine promotes a collaborative and supportive culture where employees are valued as partners. They prioritize client service, purpose, accountability, mutual respect, and collaboration, fostering a sense of teamwork and shared purpose. The company encourages personal growth through training and development, and emphasizes a focus on giving back to the community through philanthropy.

Precision for Medicine recognizes that diversity, equity and inclusion are crucial to advancing its mission of transforming drug development and maximizing benefits to patients and society. The company's ESG program reflects a commitment to creating a positive and inclusive environment for employees, fostering ethical leadership and making a positive social impact. Their 2023 ESG Report details their efforts to build a diverse and equitable workforce, engage with the communities where they operate and reduce their environmental impact.